Abstract
Aims: Tumor necrosis factor-like ligand 1A (TL1A) has been proved to activate adaptive immunity in inflammatory bowel disease (IBD). However, its role......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
